Genprex, Inc. (GNPX)
3.33
+0.09
(+2.78%)
USD |
NASDAQ |
Dec 10, 16:00
3.28
-0.05
(-1.50%)
Pre-Market: 08:21
Genprex EPS Diluted (Quarterly): -4.996 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GlucoTrack, Inc. | -4.638 |
| Arvinas, Inc. | -0.4795 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.799M |
| Total Expenses (Quarterly) | 3.799M |
| Enterprise Value | 2.241M |
| Earnings Yield | -1.05K% |
| Normalized Earnings Yield | -1049.21 |